ISSN: 1300-7777 E-ISSN: 1308-5263
Long Term Low Dose Maintenance Chemotherapy in the Treatment of Acute Myeloid Leukemia [Turk J Hematol]
Turk J Hematol. 2001; 18(2): 101-105

Long Term Low Dose Maintenance Chemotherapy in the Treatment of Acute Myeloid Leukemia

Murat Tombuloğlu, Seçkin Çağırgan
Department Of Hematology, Faculty Of Medicine, Ege University, İzmir, Turkey

In this study the effect of low dose long-term maintenance chemotherapy in patients with acute myeloid leukemia (AML) was evaluated. Following a complete remission two consolidation courses were given with the same drugs. Thereafter patients received low dose maintenance chemotherapy in every four weeks until disease relapsed or for up to two years. A total of 68 patients were evaluated. The median duration of remission of 22.5 months in patients who received maintenance chemotherapy while it was only 7 months in those without maintenance chemotherapy after a median follow-up time of 71 months, which was significant. Overall survival (OS) was also significantly longer in patients with maintenance therapy. Similar results were also obtained in comparison of patients over 60. Thus, it was concluded that maintenance therapy might be beneficial
for older AML patients with limited therapy choice.

Keywords: Acute myeloid leukemia, Maintenance chemotherapy.


Murat Tombuloğlu, Seçkin Çağırgan. Long Term Low Dose Maintenance Chemotherapy in the Treatment of Acute Myeloid Leukemia. Turk J Hematol. 2001; 18(2): 101-105

Corresponding Author: Murat Tombuloğlu, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar


 



Impact Factor (2016) = 0.686